当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › Brain Stimulation杂志
Brain Stimulation
基本信息
期刊名称 Brain Stimulation
BRAIN STIMUL
期刊ISSN 1935-861X
期刊官方网站 http://www.journals.elsevier.com/brain-stimulation/
是否OA
出版商 Elsevier Inc.
出版周期 Quarterly
始发年份 2008
年文章数 137
最新影响因子 7.7(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 CLINICAL NEUROLOGY 临床神经病学2区
NEUROSCIENCES 神经科学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 4.69 2.402 1.681
Biochemistry, Genetics and Molecular Biology
Biophysics
8 / 125 94%
Neuroscience
General Neuroscience
15 / 111 86%
Medicine
Clinical Neurology
28 / 336 91%
补充信息
自引率 10.60%
H-index 49
SCI收录状况 Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1935-861X%5BISSN%5D
投稿指南
期刊投稿网址 http://ees.elsevier.com/brs/default.asp?acw=d571d4cb7d6e5513072fb22
收稿范围

Announcement 
Brain Stimulation will become gold open access! 

At Elsevier, our goal is to provide researchers with flexible and high-quality publication options. As part of that ongoing commitment, we have been reviewing our current titles to ensure they reflect the changing needs of our authors and readers. 

Therefore, together with the Brain Stimulation Editors, we are pleased to inform you that as of January 1st, 2020 Brain Stimulation will become an open access journal with no subscription charges. 

Authors who publish in Brain Stimulation can make their work immediately, permanently, and freely accessible to researchers worldwide. Brain Stimulation authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright to their published work. 

The APC will be requested after peer review and acceptance and will be required for all accepted articles submitted after December 31st, 2019. The APC for Brain Stimulation is US$3000 (excluding any taxes). There will be no APC for letters and invited content. Most importantly, the journal's standard of excellence will not change - the journal's Editorial leadership, including Deputy Editors and Editorial Board, will remain and continue to provide the unique value Brain Stimulation brings to the field. 

Please note
Authors who submit papers on or before December 31st, 2019 will have their accepted paper published in Brain Stimulation at no charge. 

Brain Stimulation is also offering a 25% discount off the open access publication fee in 2020. For all articles submitted on or before December 31st,2020, the open access publication fee is US$2250, excluding taxes. 

About Brain Stimulation 
Brain Stimulation publishes on the entire field of brain stimulation, including noninvasive and invasive techniques and technologies that alter brain function through the use of electrical, magnetic, radiowave, or focally targeted pharmacologic stimulation. Brain Stimulation aims to be the premier journal for publication of original research in the field of neuromodulation. The journal includes: a) Original articles; b) Short Communications; c) Invited and original reviews; d) Technology and methodological perspectives (reviews of new devices, description of new methods, etc.); and e) Letters to the Editor. Special issues of the journal will be considered based on scientific merit. 

The scope of Brain Stimulation extends across the entire field of brain stimulation, including noninvasive and invasive techniques and technologies that alter brain function through the use of electrical, magnetic, radiowave, or focally targeted pharmacologic stimulation. This includes investigations that study the effects of brain stimulation on basic processes, such as gene expression and other aspects of molecular biology, neurochemical regulation, functional brain activity, sensorimotor function, and cognitive and affective processes at the systems level. 

The journal seeks the highest level of research on the biophysics and biopsychophysics of stimulation paradigms as well as the use of these techniques as a probe to outline patterns of neural connectivity. As an equal partner with this basic emphasis, the journal will have strong representation of research on the therapeutic potential and adverse effects of the stimulation technologies. The inclusion of research in therapeutics will represent not only clinical trials, but also conceptual pieces, discussions of ethics as they pertain to this field, services research, etc. 

收录体裁
Original Research
Techniques and Methods
Letter to the editor
投稿指南 https://www.elsevier.com/journals/brain-stimulation/1935-861x/guide-for-authors
投稿模板
参考文献格式 https://www.elsevier.com/journals/brain-stimulation/1935-861x/guide-for-authors
编辑信息

Editor-in-Chief

Mark S. George, MD

Medical University of South Carolina, Charleston, SC

Founding Editor

Harold A. Sackeim, PhD

Columbia University, New York, NY

Deputy Editors

Clinical Neurophysiology

John Rothwell, PhD

University College London, Queen Square, London, UK

Cognitive Neuroscience

Shirley Fecteau

Université Laval, Quebec City, Quebec, Canada

Neurology

Josep Valls-Solé, MD

Josep Valls-Solé, MD

Hospital Clinic, Barcelona, Spain

Pharmacology

Ulf Ziemann, MD

Ulf Ziemann, MD

Johann Wolfgang Goethe-University, Frankfurt, Germany

Psychiatry

Paul B. Fitzgerald, MBBS, PhD

Monash Alfred Psychiatry Research Centre, The Alfred and Monash University Central Clinical School, Melbourne, Victoria, Australia

Technology and Modeling

Marom Bikson, PhD

The City College of New York, New York

Neurosurgery

Zelma Kiss, MD, PhD

University of Calgary, Calgary, Alberta, Canada

Basic Science

Randolph J. Nudo, PhD

University of Kansas Medical Center, Kansas City, KS

Editorial Board

Chittaranjan Andrade, MD

Department of Psychopharmacology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, India

Andrea Antal, PhD

Universitätsmedizin Göttingen, Gottingen, Germany

Jeffrey Borckardt, PhD

Medical University of South Carolina, Charleston, SC, USA

Jeong-Ho Chae, MD, PhD

Department of Psychiatry, St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea

Vincent P. Clark, PhD

Department of Psychology, University of New Mexico, Albuquerque, NM, USA

Joseph Classen, MD

Department of Neurology, University of Leipzig, Leipzig, Germany

Volker A. Coenen, MD

Uniklinikum Freiburg, Neurozentrum, Klinik für Neurochirurgie, Frieiberg, Germany

Vincenzo Di Lazzaro, PhD

Institute of Neurology, Università Campus Bio-Medico, Rome, Italy

Dominique M. Durand, PhD

Department of Biomedical Engineering, Neural Engineering Center, Case Western Reserve University, Cleveland, OH, USA

Felipe Fregni, MD, PhD

Department of Physical Medicine & Rehabilitation, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

Warren M. Grill, PhD

Department of Biomedical Engineering, Duke University, Durham, NC, USA

Suzanne Haber, PhD

University of Rochester School of Medicine and Dentistry, Rochester, NY, USA

Mark Hallett, MD

Mark Hallett, MD

National Institute of Health (NIH), Bethesda, MD, USA

Masashi Hamada, MD, PhD

Department of Neurology, The University of Tokyo, Tokyo, Japan

Ritsuko Hanajima, MD, PhD

Department of Neurology, The University of Tokyo, Tokyo, Japan

Michal Lavidor, PhD

Cognitive Neuroscience Laboratory, The Gonda Multidisciplinary Brain Research Center, Bar-llan University, Ramat-Gan, Israel

Yongjie Li, MD

Department of Neurology, Beijing Kuangwuju Hospital, Beijing, China

Colleen Loo, MB BS UNSW MD, FRANZCP

The Black Dog Institute, Randwick, New South Wales, Australia

Andres Lozano, MD,PhD

Toronto Western Hospital, Toronto, Canada

Helen S. Mayberg, MD

Department of Psychiatry, Emory University School of Medicine, Atlanta, GA, USA

Cameron C. McIntyre, PhD

Case Western Reserve University School of Medicine, Cleveland, OH, USA

Michael Nitsche, MD

Department of Clinical Neurophysiology, Gottingen, Germany

Alexander Opitz, PhD

University of Minnesota, Minneapolis, Minnesota, USA

Walter Paulus, MD

Department of Clinical Neurophysiology, Gottingen, Germany

Angel V. Peterchev, PhD

Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA

Simone Rossi, MD, PhD

Department of Neuroscience, Section of Neurology, University of Siena, Siena, Italy

Andre Russowsky Brunoni, MD, PhD

Universidade de São Paulo (USP), Sào Paulo, Brazil

Hartwig Siebner, MD, PhD

Danish Research Centre for Magnetic Resonance, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark

A.P. Strafella, MD, PhD

Toronto Western Hospital, Research Institute, University of Toronto, Toronto, Ontario, Canada

Peter Tass, MD, PhD

Institute of Neuroscience and Biophysics Medicine Research Center Jülich, Jülich, Germany

Gregor Thut

Inst. of Neuroscience and Psychology, University of Glasgow, Glasgow, Scotland, UK

Yoshikazu Ugawa, MD, PhD

School of Medicine, Fukushima Medical University, Fukushima, Japan

Christine Winter, PhD

Department of Psychiatry and Psychotherapy, Technical University of Dresden, Dresden, Germany

Abraham Zangen, PhD

Ben-Gurion University, Beer-Sheva, Israel

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug